Home
/
NANOVIRICIDES, INC.
/
Financials
/
Quarterly
NANOVIRICIDES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NANOVIRICIDES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2012
Mar 31, 2012
$0
May 21, 2012
Q2
2012
Dec 31, 2011
$0
Feb 14, 2012
Q1
2012
Sep 30, 2011
$0
Dec 12, 2011
Q3
2012
Mar 31, 2011
$0
May 21, 2012
Q2
2012
Dec 31, 2010
$0
Feb 14, 2012
Q1
2012
Sep 30, 2010
$0
Dec 12, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($2.22M)
Feb 17, 2026
Q1
2026
Sep 30, 2025
($1.79M)
Nov 14, 2025
Q2
2026
Sep 30, 2025
($1.79M)
Feb 17, 2026
Q3
2025
Mar 31, 2025
($2.22M)
May 15, 2025
Q3
2025
Dec 31, 2024
($2.03M)
May 15, 2025
Q2
2026
Dec 31, 2024
($2.03M)
Feb 17, 2026
Q2
2026
Sep 30, 2024
($3.13M)
Feb 17, 2026
Q1
2026
Sep 30, 2024
($3.13M)
Nov 14, 2025
Q3
2025
Sep 30, 2024
($3.13M)
May 15, 2025
Q3
2025
Mar 31, 2024
($1.85M)
May 15, 2025
Q3
2025
Dec 31, 2023
($2.11M)
May 15, 2025
Q2
2025
Dec 31, 2023
($2.11M)
Feb 14, 2025
Q2
2025
Sep 30, 2023
($1.97M)
Feb 14, 2025
Q3
2025
Sep 30, 2023
($1.97M)
May 15, 2025
Q1
2025
Sep 30, 2023
($1.97M)
Nov 14, 2024
Q3
2024
Mar 31, 2023
($1.70M)
May 15, 2024
Q3
2024
Dec 31, 2022
($1.75M)
May 15, 2024
Q2
2024
Dec 31, 2022
($1.75M)
Feb 14, 2024
Q3
2024
Sep 30, 2022
($1.57M)
May 15, 2024
Q2
2024
Sep 30, 2022
($1.57M)
Feb 14, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($2.23M)
Feb 17, 2026
Q1
2026
Sep 30, 2025
($1.80M)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($2.25M)
May 15, 2025
Q2
2026
Dec 31, 2024
($2.06M)
Feb 17, 2026
Q1
2026
Sep 30, 2024
($3.17M)
Nov 14, 2025
Q3
2025
Mar 31, 2024
($1.91M)
May 15, 2025
Q2
2025
Dec 31, 2023
($2.18M)
Feb 14, 2025
Q1
2025
Sep 30, 2023
($2.03M)
Nov 14, 2024
Q3
2024
Mar 31, 2023
($1.81M)
May 15, 2024
Q2
2024
Dec 31, 2022
($1.83M)
Feb 14, 2024
Q1
2024
Sep 30, 2022
($1.62M)
Nov 14, 2023
Q3
2023
Mar 31, 2022
($1.79M)
May 15, 2023
Q2
2023
Dec 31, 2021
($1.92M)
Feb 14, 2023
Q1
2023
Sep 30, 2021
($2.61M)
Nov 14, 2022
Q3
2022
Mar 31, 2021
($2.11M)
May 16, 2022
Q2
2021
Dec 31, 2020
($2.29M)
Feb 14, 2022
Q1
2021
Sep 30, 2020
($2.27M)
Nov 15, 2021
Q3
2021
Mar 31, 2020
($2.54M)
May 14, 2021
Q2
2021
Dec 31, 2019
($1.63M)
Feb 16, 2021
Q1
2020
Sep 30, 2019
($1.99M)
Nov 16, 2020